Skip to content

Advertisement

BMC Urology

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer

  • Hae Su Kim1, 2,
  • Ji Yun Lee1,
  • Su Jin Lee1,
  • Ho Yeong Lim1,
  • Hyun Hwan Sung3,
  • Hwang Gyun Jeon3,
  • Byong Chang Jeong3,
  • Seong Il Seo3,
  • Seong Soo Jeon3,
  • Hyun Moo Lee3,
  • Han-Yong Choi3 and
  • Se Hoon Park1Email authorView ORCID ID profile
BMC UrologyBMC series – open, inclusive and trusted201717:63

https://doi.org/10.1186/s12894-017-0253-z

Received: 21 July 2016

Accepted: 11 August 2017

Published: 22 August 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
21 Jul 2016 Submitted Original manuscript
30 Apr 2017 Reviewed Reviewer Report - Omer Kucuk
25 May 2017 Reviewed Reviewer Report - Howard Gurney
21 Jul 2017 Author responded Author comments - Hae Su Kim
Resubmission - Version 2
21 Jul 2017 Submitted Manuscript version 2
25 Jul 2017 Author responded Author comments - Hae Su Kim
Resubmission - Version 3
25 Jul 2017 Submitted Manuscript version 3
3 Aug 2017 Author responded Author comments - Hae Su Kim
Resubmission - Version 4
3 Aug 2017 Submitted Manuscript version 4
Publishing
11 Aug 2017 Editorially accepted
22 Aug 2017 Article published 10.1186/s12894-017-0253-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine
(2)
Department of Hematology-Oncology, Department of Medicine, Veterans Health Service Medical Center
(3)
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine

Advertisement